Jay Lichter insider trades: Janux Therapeutics (JANX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jay reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | JANX | ↓ Sell | 762,471 | $46.34 | $35.3M | Direct | Oct 18, 2024 (0d) |
| Oct 18, 2024 | JANX | ↓ Sell | 735,344 | $46.09 | $33.9M | By Avalon BioVentures SPV I, L.P. | Oct 18, 2024 (0d) |
| Oct 18, 2024 | JANX | ↓ Sell | 145,219 | $46.27 | $6.7M | By Avalon BioVentures I, LP | Oct 18, 2024 (0d) |
| Oct 16, 2024 | JANX | ↓ Sell | 30,094 | $50.61 | $1.5M | By Avalon BioVentures SPV I, LP | Oct 18, 2024 (2d) |
| Sep 30, 2024 | JANX | ↓ Sell | 140,489 | $46.95 | $6.6M | Direct | Sep 30, 2024 (0d) |
| Sep 27, 2024 | JANX | ↓ Sell | 98,942 | $46.62 | $4.6M | By Avalon BioVentures SPV I, L.P. | Sep 30, 2024 (3d) |
| Sep 27, 2024 | JANX | ↓ Sell | 26,687 | $46.96 | $1.3M | By Avalon BioVentures I, LP | Sep 30, 2024 (3d) |
| Sep 26, 2024 | JANX | ↓ Sell | 41,661 | $47.77 | $2.0M | By Avalon BioVentures SPV I, LP | Sep 30, 2024 (4d) |
| Sep 13, 2024 | JANX | ↓ Sell | 3,815 | $46.68 | $178K | Direct | Oct 24, 2024 (41d) |
| Sep 12, 2024 | JANX | ↓ Sell | 203,676 | $46.89 | $9.6M | Direct | Sep 12, 2024 (0d) |
| Sep 12, 2024 | JANX | ↓ Sell | 196,403 | $46.94 | $9.2M | By Avalon BioVentures SPV I, LP | Sep 12, 2024 (0d) |
| Sep 12, 2024 | JANX | ↓ Sell | 39,455 | $46.89 | $1.9M | By Avalon BioVentures I, LP | Sep 12, 2024 (0d) |
| Sep 10, 2024 | JANX | ↓ Sell | 11,557 | $46.13 | $533K | By Avalon BioVentures SPV I, L.P. | Sep 12, 2024 (2d) |
| Sep 9, 2024 | JANX | ↓ Sell | 110,547 | $42.01 | $4.6M | Direct | Sep 10, 2024 (1d) |
| Sep 6, 2024 | JANX | ↓ Sell | 110,644 | $42.00 | $4.6M | By Avalon BioVentures SPV I, L.P. | Sep 10, 2024 (4d) |
| Sep 6, 2024 | JANX | ↓ Sell | 20,991 | $42.00 | $882K | By Avalon BioVentures I, LP | Sep 10, 2024 (4d) |
| Jun 3, 2024 | JANX | ↓ Sell | 691,525 | $54.75 | $37.9M | By Avalon BioVentures SPV I, L.P. | Jun 5, 2024 (2d) |
| Jun 3, 2024 | JANX | ↓ Sell | 677,279 | $54.75 | $37.1M | By Avalon Ventures XI, L.P. | Jun 5, 2024 (2d) |
| Jun 3, 2024 | JANX | ↓ Sell | 131,196 | $54.75 | $7.2M | By Avalon BioVentures I, LP | Jun 5, 2024 (2d) |
| Nov 13, 2023 | JANX | ↑ Buy | 849,854 | $5.87 | $5.0M | Indirect | Nov 15, 2023 (2d) |
| Jun 15, 2021 | JANX | ↑ Buy | 629,411 | $17.00 | $10.7M | Indirect | Jun 16, 2021 (1d) |
| Mar 3, 2021 | OTIC | ↓ Sell | 321,180 | $2.70 | $867K | Indirect | Mar 3, 2021 (0d) |
| Mar 2, 2021 | OTIC | ↓ Sell | 893,828 | $2.87 | $2.6M | Indirect | Mar 2, 2021 (0d) |
| Feb 25, 2021 | OTIC | ↓ Sell | 1,082,353 | $2.95 | $3.2M | Indirect | Feb 25, 2021 (0d) |
| Dec 11, 2018 | THOR | ↑ Buy | 545,455 | $11.00 | $6.0M | By Avalon X SPV I, L.P. | Dec 13, 2018 (2d) |
| Aug 18, 2014 | OTIC | ↑ Buy | 109,375 | $16.00 | $1.8M | Indirect | Aug 19, 2014 (1d) |
| Aug 18, 2014 | OTIC | ↓ Sell | 50,001 | $16.00 | $800K | Indirect | Aug 19, 2014 (1d) |
| Feb 3, 2014 | PETX | ↓ Sell | 825,000 | $19.00 | $15.7M | By Limited Partnership | Feb 5, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JANX insiders
Open-market trades in the last 12 months
About Jay Lichter's insider trades
Jay Lichter is a 10% owner of Janux Therapeutics (JANX). Since Feb 3, 2014, Jay has reported 4 open-market purchases worth $23.4M and 24 sales worth $228.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), option exercises (6 filings), conversions (4 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JANX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.